Pratyusha Bala
Affiliations: | 2021-2024 | Medical Oncology | Dana-Farber Cancer Institute, Boston, MA, United States |
Google:
"Pratyusha Bala"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zhang F, Sahu V, Peng K, et al. (2024) Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut |
Spisak S, Chen D, Likasitwatanakul P, et al. (2024) Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system. Nature Communications. 15: 2230 |
Spisak S, Chen D, Likasitwatanakul P, et al. (2024) Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer. Biorxiv : the Preprint Server For Biology |
Sahgal P, Patil DT, Bala P, et al. (2023) Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. Iscience. 26: 108169 |
Bala P, Rennhack JP, Aitymbayev D, et al. (2023) Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Science Advances. 9: eadf0927 |
Bala P, Kavadipula P, Sarkar S, et al. (2022) To β or Not to β: Lack of Correlation Between APC Mutation and β-Catenin Nuclear Localization in Colorectal Cancer. Journal of Gastrointestinal Cancer |
Tanton H, Sewastianik T, Seo HS, et al. (2022) A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Science Advances. 8: eabm3108 |
Liang X, Duronio GN, Yang Y, et al. (2021) An enhancer-driven stem cell-like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer. Gastroenterology |
Bala P, Singh AK, Kavadipula P, et al. (2020) Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer. Oncogene |
Bashyam MD, Animireddy S, Bala P, et al. (2019) The Yin and Yang of cancer genes. Gene. 704: 121-133 |